White lesions of the oral cavity

Dermatologic Clinics

Volumn 21, Issue 1, 2003, Pages 63-78

  Messadi, Diana V ^a   Waibel, Jill S ^b   Mirowski, Ginat W ^c,d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b WRIGHT STATE UNIVERSITY   (United States)

^c INDIANA UNIVERSITY SCHOOL OF DENTISTRY   (United States)

^d INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2A INTERFERON; AMPHOTERICIN B; ANTIFUNGAL AGENT; BENZATHINE PENICILLIN; BENZOIN; BETA INTERFERON; BLEOMYCIN; CLOTRIMAZOLE; CORTICOSTEROID; DAPSONE; FLUCONAZOLE; FLUCYTOSINE; ITRACONAZOLE; KETOCONAZOLE; NYSTATIN; PODOPHYLLIN; PYRROLE DERIVATIVE; RETINOID; SALAZOSULFAPYRIDINE;

CANCER; CLINICAL EXAMINATION; CLINICAL FEATURE; CONDYLOMA ACUMINATUM; CONGENITAL PACHYONYCHIA; DARIER DISEASE; DIFFERENTIAL DIAGNOSIS; DISCOID LUPUS ERYTHEMATOSUS; DYSKERATOSIS CONGENITA; FOCAL EPITHELIUM HYPERPLASIA; HUMAN; INFECTION; KERATOSIS; KIDNEY DISEASE; LASER SURGERY; LEUKOPLAKIA; MOUTH LESION; PAPILLOMATOSIS; PRIORITY JOURNAL; REVIEW; SMOKING; SQUAMOUS CELL CARCINOMA; STOMATITIS; SYPHILIS; THRUSH; TYLOSIS; VERRUCA VULGARIS;

DIAGNOSIS, DIFFERENTIAL; HUMANS; MOUTH DISEASES; MOUTH NEOPLASMS;

EID: 0037287129     PISSN: 07338635     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0733-8635(02)00069-4     Document Type: Review

References (50)

1. Neville BD, Damm DD, Allen CM, Bouquot JE. Oral and maxillofacial pathology. Philadelphia: WB Saunders; 1995. p. 211-2.
2. Terrinoni A, Rugg EL, Lane EB, et al. A novel mutation in the keratin 13 gene causing oral white sponge nevus. J Dent Res 2001;80:919-23.
3. Eisen D, Lynch DP. Genodermatoses. In: Eisen D, Lynch DP, editors. The mouth: diagnosis and treatment. St. Louis: Mosby; 1998. p. 193-4.
4. Available at: http.www3.ncbi.nlm.nih.gov/Omim/searchomim.html. Accessed January 2002.
5. Munro CS, Mastana SS, Papiha SS. Mapping of the Darier's disease gene by serogenetic markers: results in two large British kindreds. Ann Genet 1992;35:157-60.
6. Craddock N, Dawson E, Burge S, et al. The gene for Darier's disease maps to chromosome 12q23-q24.1. Hum Mol Genet 1993;2:1941-3.
7. Bashir R, Munro CS, Mason S, Stephenson A, Rees JL, Strachan T. Localization of a gene for Darier's disease. Hum Mol Genet 1993;2:1937-9.
8. Buxton RS. Yet another skin defect, Darier's disease, maps to chromosome 12q. Hum Mol Genet 1993;2:1763-4.
9. Davidson HR, Connor JM. Dyskeratosis congenita. J Med Genet 1988;25:843-6.
10. Kagoura M, Morohashi M. Dyskeratosis congenita: a light microscopic and ultrastructural study. Eur J Dermatol 1998;8:307-9.
11. Tchou PK, Kohn T. Dyskeratosis congenita: an autosomal dominant disorder. J Am Acad Dermatol 1982;6:1034-9.
12. Vulliamy T, Marrone A, Goldman F, Dearlove A, Bessler M, Mason PJ, et al. The RNA component of telomerase is mutated in autosomal dominant dyskeratosis congenita. Nature 2001;413:432-5.
13. Eisen D, Lynch DP. Viral infections. In: Eisen D, Lynch DP, editors. The mouth: diagnosis and treatment. St. Louis: Mosby; 1998. p. 108-27.
14. Flaitz CM. Focal epithelial hyperplasia: a multifocal oral human papillomavirus infection. Pediatr Dent 2000;22:153-4.
15. Tan AK, Tewfik TL, Moroz B, et al. Focal epithelial hyperplasia. Otolaryngol Head Neck Surg 1995;112:316-9.
16. Archard HO, Heck JW, Stanley HR. Focal epithelial hyperplasia: an unusual mucosal lesion found in Indian children. Oral Surg 1965;20:201-12.
17. Steinhoff M, Metze D, Stockfleth E, et al. Successful topical treatment of focal epithelial hyperplasia (Heck's disease) with interferon-α. Br J Dermatol 2001;144:1067-9.
18. Jorizzo JL, Salisbury PL, Rogers III RS, et al. Oral lesions in systemic lupus erythematosus: do ulcerative lesions represent a necrotizing vasculitis? J Am Acad Dermatol 1992;27:389-94.
19. Burge SM, Frith PA, Juniper RP, Wojnarowska F. Mucosal involvement in systemic and chronic cutaneous lupus erythematosus. Br J Dermatol 1989;121:727-41.
20. Ballo FS, Gamisa C, Allen C. Pyostomatitis vegetans. J Am Acad Dermatol 1989;21:381-7.
21. Van Hale HM, Rogers III RS, Zone JJ, Greipp PR. Pyostomatitis vegetans. Arch Dermatol 1985;121:94-8.
22. Thornhill MH, Zakrzewska JM, Gilkes JJ. Pyostomatitis vegetans: report of three cases and review of the literature. J Oral Pathol Med 1992;21:128-33.
23. Hansen LS, Olson JA, Silverman S. Proliferative verrucous leukoplakia. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1985;60:285-98.
24. Batsakis JG, Suarez P, El-Naggar A. Proliferative verrucous leukoplakia and its related lesions. Oral Oncol 1999;35:354-9.
25. Silverman S, Gorsky M. Proliferative verrucous leukoplakia: a follow- up study of 54 cases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1997;84:154-7.
26. Palefsky JM, Silverman S, Abdel Salaam M, et al. Association between proliferative verrucous leukoplakia and infection with human papillomavirus type 16. J Oral Pathol Med 1995;24:193-7.
27. Fettig A, Pogrel AM, Silverman S, et al. Proliferative verrucous leukoplakia of the gingival. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2000;90:723-30.
28. Collangettes S, Chollet P, Fonck Y. Oral florid papillomatosis. Oral Oncol 1993;29B:81-2.
29. Appleton SS. Candidiasis: pathogenesis, clinical characteristics, and treatment. Calif Dent Assoc J 2000;28:942-8.
30. Eisen D, Lynch DP. Fungal infections. In: Eisen D, Lynch DP, editors. The mouth: diagnosis and treatment. St. Louis: Mosby; 1998. p. 128-34.
31. Kurzai O, Wemer JH, et al. Rapid PCR test for discriminating between Candida albicans and Candida dubliniensis isolates using primers derived from the pH-regulated PHR1 and PHR2 genes of C. albicans. J Clin Microbiol 1999;37:1587-90.
32. Staab JF, Bradway SD, et al. Adhesive and mammalian transglutaminase substrate properties of Candida albicans Hwp1. Science 1999;283:1535-7.
33. Greenspan D, Canchola AJ, MacPhail LA, et al. Effect of highly active antiretroviral therapy on frequency of oral warts. Lancet 2001;357:1411-2.
34. Neville BD, Damm DD, Allen CM, Bouquot JE. Oral and maxillofacial pathology. Philadelphia: WB Saunders; 1995. p. 542-3.
35. Eisen D, Lynch DP. The mouth: diagnosis and treatment. St. Louis: Mosby; 1998. p. 58-91.
36. Lee JJ, Hong WK, Hittleman WN, et al. Predicting cancer development in oral leukoplakia: ten years of translational research. Clin Cancer Res 2000;6:1702-10.
37. Eisen D, Lynch DP. The mouth: diagnosis and treatment. St. Louis: Mosby; 1998. p. 20-36.
38. Frankos VH, Brusik DJ, Johnson EM, et al. Safety of sanguinaria extract as used in commercial toothpaste and oral rinses products. J Can Dent Assoc 1990;56:41-7.
39. Harper DS, Mueller LJ, Fine JB, et al. Clinical efficacy of a dentifrice and oral rinse containing sanguinaria extract and zinc chloride during 6 months of use. J Periodontol 1990;61:352-8.
40. Harper DS, Mueller LJ, Fine JB, et al. Effect of 6 months use of a dentifrice and oral rinse containing sanguinaria extract and zinc chloride upon microflora of the dental plaque and oral soft tissues. J Periodontol 1990b;61:359-63.
41. Kuftinec MM, Mueller-Joseph LJ, Kopczyk RA. Sanguinaria toothpaste and oral rinse regimen clinical efficacy in short-and-long term trials. J Can Dent Assoc 1990;56:31-5.
42. Damm DD, Curran A, White DK, et al. Leukoplakia of the maxillary vestibule: an association with Viadent? Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1999;87:61-6.
43. Munro IC, Delzell ES, et al. Viadent usage and oral leukoplakia: a spurious association. Regul Toxicol and Pharmacol 1999;30:182-96.
44. Field EA, Ellis A, Friedmann PS, Leigh IM, Field JK. Oral tylosis: a re-appraisal. Oral Oncol 1997;33:55-7.
45. Ashworth MT, Nash JR, Ellis A, Day DW. Abnormalities of differentiation and maturation in the esophageal squamous epithelium of patients with tylosis: morphological features. Histopathology 1991;19:303-10.
46. Mirbod SM, Ahing SI. Tobacco associated lesions of the oral cavity. Part I. Nonmalignant lesions. J Can Dent Assoc 2000;66:252-6.
47. Martin GC, Brown JP, Eifler CW, et al. Oral leukoplakia status six weeks after cessation of smokeless tobacco use. J American Dental Association 1999;130:945-54.
48. Regezi J, Sciubba J. Ulcerative conditions. In: Regezi J, Sciubba J, editors. Oral pathology: clinical pathological correlations. 3rd edition. Philadelphia: WB Saunders; 1999. p. 69-81.
49. Neville BD, Damm DD, Allen CM, Bouquot JE. Epithelial pathology. In: Oral and maxillofacial pathology. Philadelphia: WB Saunders; 1995. p. 263-5.
50. Storwick SG, Prihoda BM, Fulton JR, Wood SW. Pyodermatitis pyostomatitis vegetans: a specific marker for inflammatory bowel disease. J Am Acad Dermatol 1994;31:336-41.